home > bioproject > PRJEB1281
identifier PRJEB1281
type bioproject
sameAs
organism
title Praziquantel mode of action and resistance
description This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/The drug Praziquantel is the most commonly used drug for parasitic flatworms. It is currently being increasingly used in mass drug administration programmes, raising concerns over whether resistance will develop. Although widely used, its mode of action was until very recently uncertain. This study will investigate the praziquantel mode of action and resistance by sequencing the transcriptomes of Dugesia japonica and different stages and strains of S. mansoni.
data type Transcriptome or Gene expression
organization
publication
properties 
{...}
dbXrefs
sra-run  ERR273945ERR273946ERR273947ERR273948ERR273949ERR273950ERR273951ERR273952ERR273953ERR273954 More
sra-submission  ERA212584ERA222824ERA223718ERA281395ERA337205ERA340768ERA346684ERA349605ERA352204ERA354963
biosample  SAMEA1889134SAMEA1889131SAMEA1889128SAMEA1889125SAMEA1889121SAMEA1889133SAMEA1889129SAMEA1889117SAMEA1889137SAMEA1889136 More
sra-study  ERP002113
sra-sample  ERS204891ERS204892ERS204893ERS204894ERS204895ERS204896ERS204897ERS204898ERS204899ERS204900 More
sra-experiment  ERX248221ERX248222ERX248223ERX248224ERX248225ERX248226ERX248227ERX248228ERX248229ERX248230 More
distribution JSONJSON-LD
Download
bioproject.xml  HTTPS FTP
status public
visibility unrestricted-access
dateCreated 2013-01-09T00:00:00Z
dateModified 2013-01-09T00:00:00Z
datePublished 2013-01-09T00:00:00Z